Published: 15 Aug 2025 365 views
The University of East Anglia are calling for applications for this fully funded PhD studentship in Breast Cancer Treatment. This PhD project seeks to investigate effect of combined treatment with ITCs and a selected anti-cancer drug (sorafenib or triptolide) on breast cancer will be studied using MDA-MB-231 and MCF-7 breast cancer cells, and a normal breast cell line MCF-10A. Cell viability assays, colony formation, and flow cytometry analysis will be used to assess the anti-cancer effects.
The combination index will be calculated, and the selected pair of drugs which have synergy will be further studied.
Effects on cell migration, invasion, angiogenesis, and tumour microenvironment (TME) will be studied using a range of assays established in-house. The effects of drugs given alone will be compared with combined treatments
This project is jointly funded for three years by the Cancer Prevention Research Trust. Funding includes tuition fees at Home-fee rate, an annual stipend for maintenance starting at £20,780 in the academic year 2025/26, and £1,000 per annum to support research training.
Overseas applicants may apply but they are required to self-fund the difference in fee rates. Please see View Website for details of Home and International tuition fees.
The minimum entry requirement is 2:1. in?? Biological sciences; cell & molecular biology, oncology, biomedicine?.
For more details, visit University of East Anglia Scholarship webpage
A friend or someone might be interested in this opportunity, kindly share.
